Crossref
Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient
Journal of Parathyroid Disease · 2017
DOI: 10.15171/jpd.2018.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parathyroid Disease, 2017. Verfasst von Mansoor Karimifar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Karimifar, M., & Karimifar, M. (2017). Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient. Journal of Parathyroid Disease. https://doi.org/10.15171/jpd.2018.12
Vancouver
Karimifar M, Karimifar M. Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient. Journal of Parathyroid Disease. 2017. doi:10.15171/jpd.2018.12
BibTeX
@article{Karimifar2017,
author = {Karimifar, Mansoor and Karimifar, Mozhgan},
title = {Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient},
journal = {Journal of Parathyroid Disease},
year = {2017},
doi = {10.15171/jpd.2018.12}
}
EUVIMED